Tech Company Financing Transactions

Sangart Funding Round

Sangart closed a $50 million venture capital round on 4/20/2011. Investors included Leucadia National Corp and private investors.

Transaction Overview

Company Name
Announced On
4/20/2011
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors

Leucadia National Corp (Lead Investor)

Proceeds Purpose
This series G funding will allow us to continue advancing the development of our medicines and get them as quickly as possible to patients in need. We continue to see promise in our MP4-based medicines in the treatment of patients who experience an acute traumatic injury and in patients with sickle cell disease suffering from a vaso-occlusive crisis.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6175 Lusk Blvd
San Diego, CA 92121
USA
Email Address
Overview
Sangart, Inc. is a biopharmaceutical company focused on the research, development and commercialization of oxygen transport agents.
Profile
Sangart LinkedIn Company Profile
Social Media
Sangart Company Twitter Account
Company News
Sangart News
Facebook
Sangart on Facebook
YouTube
Sangart on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Brian O'Callaghan
  Brian O'Callaghan LinkedIn Profile  Brian O'Callaghan Twitter Account  Brian O'Callaghan News  Brian O'Callaghan on Facebook
Chief Financial Officer
David Renas
  David Renas LinkedIn Profile  David Renas Twitter Account  David Renas News  David Renas on Facebook
Chief Medical Officer
Frank Booth
  Frank Booth LinkedIn Profile  Frank Booth Twitter Account  Frank Booth News  Frank Booth on Facebook
Chief Operating Officer
Don Brown
  Don Brown LinkedIn Profile  Don Brown Twitter Account  Don Brown News  Don Brown on Facebook
Chief Scientific Officer
Kenneth Burhop
  Kenneth Burhop LinkedIn Profile  Kenneth Burhop Twitter Account  Kenneth Burhop News  Kenneth Burhop on Facebook
VP - Human Resources
Kristine Figueroa
  Kristine Figueroa LinkedIn Profile  Kristine Figueroa Twitter Account  Kristine Figueroa News  Kristine Figueroa on Facebook
VP - Regulatory Affairs
Carmen Betancourt-Riche
  Carmen Betancourt-Riche LinkedIn Profile  Carmen Betancourt-Riche Twitter Account  Carmen Betancourt-Riche News  Carmen Betancourt-Riche on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/20/2011: Link Medicine venture capital transaction
Next: 4/20/2011: Decide.com venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary